WEE1 and breast carcinoma: In a model for the clinical scenario of breast cancer cells resistant to endocrine therapy and CDK4/6 inhibitors, derived long-term estrogen deprived endocrine resistant cell lines were found to be more resistant to CDK4/6 inhibitors, but more sensitive to AZD1775 or Wee1 knockdown than their parental cell lines (130).